These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28471483)

  • 1. Bone Marrow-Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus Have a Senescence-Associated Secretory Phenotype Mediated by a Mitochondrial Antiviral Signaling Protein-Interferon-β Feedback Loop.
    Gao L; Bird AK; Meednu N; Dauenhauer K; Liesveld J; Anolik J; Looney RJ
    Arthritis Rheumatol; 2017 Aug; 69(8):1623-1635. PubMed ID: 28471483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow mesenchymal stem cells from patients with SLE maintain an interferon signature during in vitro culture.
    Gao L; OConnell M; Allen M; Liesveld J; McDavid A; Anolik JH; Looney RJ
    Cytokine; 2020 Aug; 132():154725. PubMed ID: 31153744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN
    Gao L; Liesveld J; Anolik J; Mcdavid A; Looney RJ
    Lupus; 2020 Aug; 29(9):1040-1049. PubMed ID: 32515653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53/p21 Pathway involved in mediating cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients.
    Gu Z; Jiang J; Tan W; Xia Y; Cao H; Meng Y; Da Z; Liu H; Cheng C
    Clin Dev Immunol; 2013; 2013():134243. PubMed ID: 24151513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/β-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway.
    Gu Z; Tan W; Feng G; Meng Y; Shen B; Liu H; Cheng C
    Mol Cell Biochem; 2014 Feb; 387(1-2):27-37. PubMed ID: 24130040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK-STAT signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients.
    Ji J; Wu Y; Meng Y; Zhang L; Feng G; Xia Y; Xue W; Zhao S; Gu Z; Shao X
    Acta Biochim Biophys Sin (Shanghai); 2017 Mar; 49(3):208-215. PubMed ID: 28177455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion-like Aggregation of Mitochondrial Antiviral Signaling Protein in Lupus Patients Is Associated With Increased Levels of Type I Interferon.
    Shao WH; Shu DH; Zhen Y; Hilliard B; Priest SO; Cesaroni M; Ting JP; Cohen PL
    Arthritis Rheumatol; 2016 Nov; 68(11):2697-2707. PubMed ID: 27110677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin and Neutrophil-Activating Peptide 2 Promote Mesenchymal Stem Cell Senescence Through Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway in Patients With Systemic Lupus Erythematosus.
    Chen H; Shi B; Feng X; Kong W; Chen W; Geng L; Chen J; Liu R; Li X; Chen W; Gao X; Sun L
    Arthritis Rheumatol; 2015 Sep; 67(9):2383-93. PubMed ID: 25989537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting HMGB1 by ethyl pyruvate ameliorates systemic lupus erythematosus and reverses the senescent phenotype of bone marrow-mesenchymal stem cells.
    Ji J; Fu T; Dong C; Zhu W; Yang J; Kong X; Zhang Z; Bao Y; Zhao R; Ge X; Sha X; Lu Z; Li J; Gu Z
    Aging (Albany NY); 2019 Jul; 11(13):4338-4353. PubMed ID: 31303606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restored immunosuppressive effect of mesenchymal stem cells on B cells after olfactory 1/early B cell factor-associated zinc-finger protein down-regulation in patients with systemic lupus erythematosus.
    Feng X; Che N; Liu Y; Chen H; Wang D; Li X; Chen W; Ma X; Hua B; Gao X; Tsao BP; Sun L
    Arthritis Rheumatol; 2014 Dec; 66(12):3413-23. PubMed ID: 25219468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of p16INK4A promotes cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients.
    Gu Z; Cao X; Jiang J; Li L; Da Z; Liu H; Cheng C
    Cell Signal; 2012 Dec; 24(12):2307-14. PubMed ID: 22820504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.
    Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C
    Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN/Akt-p27(kip1) Signaling Promote the BM-MSCs Senescence and Apoptosis in SLE Patients.
    Tan W; Gu Z; Shen B; Jiang J; Meng Y; Da Z; Liu H; Tao T; Cheng C
    J Cell Biochem; 2015 Aug; 116(8):1583-94. PubMed ID: 25649549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus.
    Geng L; Tang X; Wang S; Sun Y; Wang D; Tsao BP; Feng X; Sun L
    Front Immunol; 2020; 11():233. PubMed ID: 32133007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
    Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
    Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of miR-20a-5p in mesenchymal stem cell derived-exosomes from systemic lupus erythematosus patients restored therapeutic effect and Treg immune regulation.
    Ji J; Liang Q; He Q; Chen T; Feng G; Guo H; Wang Y; Xu Y; Chen P; Dong C; Zhao R; Yang J; Sha X; Cao H; Li J; Xia Y; Yang M; Gu Z
    Eur J Pharmacol; 2024 Sep; 979():176862. PubMed ID: 39068974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy.
    Cipriani P; Di Benedetto P; Liakouli V; Del Papa B; Di Padova M; Di Ianni M; Marrelli A; Alesse E; Giacomelli R
    Clin Exp Immunol; 2013 Aug; 173(2):195-206. PubMed ID: 23607751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Exosomes Derived-miR-146a from Systemic Lupus Erythematosus Patients Regulates Senescence of Mesenchymal Stem Cells.
    Dong C; Zhou Q; Fu T; Zhao R; Yang J; Kong X; Zhang Z; Sun C; Bao Y; Ge X; Zhang Z; Lu Z; Li J; Zheng W; Gu Z; Ji J
    Biomed Res Int; 2019; 2019():6071308. PubMed ID: 31428639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus.
    Li X; Liu L; Meng D; Wang D; Zhang J; Shi D; Liu H; Xu H; Lu L; Sun L
    Stem Cells Dev; 2012 Sep; 21(13):2387-94. PubMed ID: 22375903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An early-senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program.
    Gnani D; Crippa S; Della Volpe L; Rossella V; Conti A; Lettera E; Rivis S; Ometti M; Fraschini G; Bernardo ME; Di Micco R
    Aging Cell; 2019 Jun; 18(3):e12933. PubMed ID: 30828977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.